BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27451459)

  • 1. Nanoparticle-Mediated Delivery of Mitochondrial Division Inhibitor 1 to the Myocardium Protects the Heart From Ischemia-Reperfusion Injury Through Inhibition of Mitochondria Outer Membrane Permeabilization: A New Therapeutic Modality for Acute Myocardial Infarction.
    Ishikita A; Matoba T; Ikeda G; Koga J; Mao Y; Nakano K; Takeuchi O; Sadoshima J; Egashira K
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27451459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
    Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
    Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-Mediated Simultaneous Targeting of Mitochondrial Injury and Inflammation Attenuates Myocardial Ischemia-Reperfusion Injury.
    Ikeda G; Matoba T; Ishikita A; Nagaoka K; Nakano K; Koga JI; Tsutsui H; Egashira K
    J Am Heart Assoc; 2021 Jun; 10(12):e019521. PubMed ID: 34056918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of mitochondrial hexokinase II dissociation during ischemia correlates with mitochondrial cytochrome c release, reactive oxygen species production, and infarct size on reperfusion.
    Pasdois P; Parker JE; Halestrap AP
    J Am Heart Assoc; 2012 Dec; 2(1):e005645. PubMed ID: 23525412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.
    Nagaoka K; Matoba T; Mao Y; Nakano Y; Ikeda G; Egusa S; Tokutome M; Nagahama R; Nakano K; Sunagawa K; Egashira K
    PLoS One; 2015; 10(7):e0132451. PubMed ID: 26167913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model.
    Ichimura K; Matoba T; Nakano K; Tokutome M; Honda K; Koga J; Egashira K
    PLoS One; 2016; 11(9):e0162425. PubMed ID: 27603665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice.
    Ding M; Dong Q; Liu Z; Liu Z; Qu Y; Li X; Huo C; Jia X; Fu F; Wang X
    Cardiovasc Diabetol; 2017 Feb; 16(1):19. PubMed ID: 28173848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury.
    Ong SB; Subrayan S; Lim SY; Yellon DM; Davidson SM; Hausenloy DJ
    Circulation; 2010 May; 121(18):2012-22. PubMed ID: 20421521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
    Lu N; Sun Y; Zheng X
    Planta Med; 2011 Jul; 77(10):984-91. PubMed ID: 21283956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamin-related protein 1 is a critical regulator of mitochondrial calcium homeostasis during myocardial ischemia/reperfusion injury.
    Piao L; Fang YH; Fisher M; Hamanaka RB; Ousta A; Wu R; Mutlu GM; Garcia AJ; Archer SL; Sharp WW
    FASEB J; 2024 Jan; 38(1):e23379. PubMed ID: 38133921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
    Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
    Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Panax quinquefolium saponin attenuates cardiomyocyte apoptosis and opening of the mitochondrial permeability transition pore in a rat model of ischemia/reperfusion.
    Li D; Liu M; Tao TQ; Song DD; Liu XH; Shi DZ
    Cell Physiol Biochem; 2014; 34(4):1413-26. PubMed ID: 25301366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution.
    Panel M; Ahmed-Belkacem A; Ruiz I; Guichou JF; Pawlotsky JM; Ghaleh B; Morin D
    J Pharmacol Exp Ther; 2021 Mar; 376(3):348-357. PubMed ID: 33303698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress.
    Townsend PA; Davidson SM; Clarke SJ; Khaliulin I; Carroll CJ; Scarabelli TM; Knight RA; Stephanou A; Latchman DS; Halestrap AP
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H928-38. PubMed ID: 17483234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria.
    Chen Q; Xu H; Xu A; Ross T; Bowler E; Hu Y; Lesnefsky EJ
    PLoS One; 2015; 10(3):e0118834. PubMed ID: 25756500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of cyclophilin D at serine 191 regulates mitochondrial permeability transition pore opening and cell death after ischemia-reperfusion.
    Hurst S; Gonnot F; Dia M; Crola Da Silva C; Gomez L; Sheu SS
    Cell Death Dis; 2020 Aug; 11(8):661. PubMed ID: 32814770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo hyperoxic preconditioning protects against rat-heart ischemia/reperfusion injury by inhibiting mitochondrial permeability transition pore opening and cytochrome c release.
    Petrosillo G; Di Venosa N; Moro N; Colantuono G; Paradies V; Tiravanti E; Federici A; Ruggiero FM; Paradies G
    Free Radic Biol Med; 2011 Feb; 50(3):477-83. PubMed ID: 21130864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK/mPTP signalling: a parallel pathway to protection.
    Bell RM; Kunuthur SP; Hendry C; Bruce-Hickman D; Davidson S; Yellon DM
    Basic Res Cardiol; 2013 Mar; 108(2):331. PubMed ID: 23361433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional preconditioning induced by astragaloside Ⅳ on isolated hearts and cardiomyocytes against myocardial ischemia injury via improving Bcl-2-mediated mitochondrial function.
    Luo Y; Wan Q; Xu M; Zhou Q; Chen X; Yin D; He H; He M
    Chem Biol Interact; 2019 Aug; 309():108723. PubMed ID: 31228469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission.
    Kalkhoran SB; Kriston-Vizi J; Hernandez-Resendiz S; Crespo-Avilan GE; Rosdah AA; Lees JG; Costa JRSD; Ling NXY; Holien JK; Samangouei P; Chinda K; Yap EP; Riquelme JA; Ketteler R; Yellon DM; Lim SY; Hausenloy DJ
    Cardiovasc Res; 2022 Jan; 118(1):282-294. PubMed ID: 33386841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.